Investigation of the Effectiveness of Upper Limb Exercise in COPD Patients

January 24, 2020 updated by: Christos Karagiannis, European University Cyprus

The aim of the study is to investigate the efficacy of upper limb exercise training in Chronic Obstructive Pulmonary Disease (COPD) patients. For the purpose of the study, a controlled trial will be conducted within Respiratory Clinic of Nicosia General Hospital. The sample will be divided in two groups. The intervention group will participate in a pulmonary rehabilitation program which includes upper and lower extremities exercises, with addition of arm ergometer. The second group (control group) will participate in the same program but without arm ergometer training.

The study's hypothesis is that the intervention group will improve the outcome measures significantly better than the control group.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Nicosia, Cyprus
        • Recruiting
        • Respiratory Clinic, Nicosia General Hospital
        • Contact:
          • Andreas Georgiou

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of COPD confirmed by clinical examination and a pulmonary function test
  • Stable clinical condition (without recent respiratory system infections or any exacerbation of the disease)
  • Patients must be willing to re evaluate at the end of the study
  • Patients must be willing to give written consent for their participation in the study

Exclusion Criteria:

  • Age < 18 years old
  • Unstable cardiac disease
  • Musculoskeletal and neurological diseases that could affect exercise performance or preclude exercise
  • Patients of COPD final stage or other serious disease final stage
  • Significant cognitive or psychiatric impairment that would lead to an inability to follow simple commands in a group setting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm Endurance Exercise Training Group
Pulmonary Rehabilitation Program including Upper Limb Endurance Exercise Training with arm cycle ergometer
Pulmonary Rehabilitation Program including Upper Limb Endurance Exercise Training with arm cycle ergometer
Other Names:
  • Pulmonary Rehabilitation
Active Comparator: Control Group
Pulmonary Rehabilitation Program without Upper Limb Endurance Exercise Training
Pulmonary Rehabilitation Program without Upper Limb Endurance Exercise Training
Other Names:
  • Pulmonary Rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper Limb Muscle Strength, biceps brachii
Time Frame: Before Intervention
Assess biceps brachii via hand-held dynamometer Micro FET2
Before Intervention
Upper Limb Muscle Strength, biceps brachii
Time Frame: At 3 months (at the end of intervention)
Assess biceps brachii via hand-held dynamometer Micro FET2
At 3 months (at the end of intervention)
Upper Limb Muscle Strength, biceps brachii
Time Frame: Change from Baseline Biceps Brachii Muscle Strength at 3 months
Assess biceps brachii via hand-held dynamometer Micro FET2
Change from Baseline Biceps Brachii Muscle Strength at 3 months
Upper Limb Muscle Strength, triceps
Time Frame: Before Intervention
Assess triceps via hand-held dynamometer Micro FET2
Before Intervention
Upper Limb Muscle Strength, triceps
Time Frame: At 3 months (at the end of intervention)
Assess triceps via hand-held dynamometer Micro FET2
At 3 months (at the end of intervention)
Upper Limb Muscle Strength, triceps
Time Frame: Change from Baseline Triceps Muscle Strength at 3 months
Assess triceps via hand-held dynamometer Micro FET2
Change from Baseline Triceps Muscle Strength at 3 months
Upper Limb Muscle Strength, hand-grip
Time Frame: Before Intervention
Assess via jamar hand dynamometer
Before Intervention
Upper Limb Muscle Strength, hand-grip
Time Frame: At 3 months (at the end of intervention)
Assess via jamar hand dynamometer
At 3 months (at the end of intervention)
Upper Limb Muscle Strength, hand-grip
Time Frame: Change from Baseline Handgrip Muscle Strength at 3 months
Assess via jamar hand dynamometer
Change from Baseline Handgrip Muscle Strength at 3 months
Dyspnea, modified Borg Scale
Time Frame: Before Intervention
Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
Before Intervention
Dyspnea, modified Borg Scale
Time Frame: At 3 months (at the end of intervention)
Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
At 3 months (at the end of intervention)
Dyspnea, modified Borg Scale
Time Frame: Change from Baseline Dyspnea at 3 months
Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
Change from Baseline Dyspnea at 3 months
Dyspnea, mMRC Scale
Time Frame: Before Intervention
Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
Before Intervention
Dyspnea, mMRC Scale
Time Frame: At 3 months (at the end of intervention)
Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
At 3 months (at the end of intervention)
Dyspnea, mMRC Scale
Time Frame: Change from Baseline Dyspnea at 3 months
Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
Change from Baseline Dyspnea at 3 months
Fatigue
Time Frame: Before Intervention
Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
Before Intervention
Fatigue
Time Frame: At 3 months (at the end of intervention)
Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
At 3 months (at the end of intervention)
Fatigue
Time Frame: Change from Baseline Fatigue at 3 months
Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
Change from Baseline Fatigue at 3 months
Health-related Quality of Life, SGRQ
Time Frame: Before Intervention
Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
Before Intervention
Health-related Quality of Life, SGRQ
Time Frame: At 3 months (at the end of intervention)
Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
At 3 months (at the end of intervention)
Health-related Quality of Life, SGRQ
Time Frame: Change from Baseline at 3 months
Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
Change from Baseline at 3 months
Health-related Quality of Life, CAT
Time Frame: Before Intervention
Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
Before Intervention
Health-related Quality of Life, CAT
Time Frame: At 3 months (at the end of intervention)
Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
At 3 months (at the end of intervention)
Health-related Quality of Life, CAT
Time Frame: Change from Baseline at 3 months
Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
Change from Baseline at 3 months
Activities of Daily Living with Upper Limbs
Time Frame: Before Intervention
Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level
Before Intervention
Activities of Daily Living with Upper Limbs
Time Frame: At 3 months (at the end of intervention)
Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level
At 3 months (at the end of intervention)
Activities of Daily Living with Upper Limbs
Time Frame: Change from Baseline time at 3 months
Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level
Change from Baseline time at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2017

Primary Completion (Anticipated)

May 31, 2020

Study Completion (Anticipated)

May 31, 2020

Study Registration Dates

First Submitted

February 14, 2019

First Submitted That Met QC Criteria

March 2, 2019

First Posted (Actual)

March 5, 2019

Study Record Updates

Last Update Posted (Actual)

January 28, 2020

Last Update Submitted That Met QC Criteria

January 24, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • ΕΕΒΚ/ΕΠ/2017/18

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Arm Endurance Exercise Training

3
Subscribe